Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Cidara Therapeutics, Inc. CDTX

Set alert

Price alert · CDTX

All alert types
221.38 USD 0.00 0.00%

As of Jan 8, 9:30 AM ET

Bid
221.38 × 2
Ask
221.39 × 2
221.38 Day range 221.38

52-week range unavailable

YTD
+0.22%
1 year
+725.74%
Open
221.38
Prev close
221.38
Mkt cap
5.61B
Vol
2.69M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
221.38
High
221.38
Beta
1.53
Inst. own
103.89%
Dividend
0.00

3M chart

Chart tools
Interval
1m5m15m30m

Events in this range
  • Oct 21, 2025Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 6, 2025Earnings: -3.1; estimate -1.34; surprise -131.34%
  • Nov 7, 2025Rating: Needham · Buy → Buy
  • Nov 7, 2025Rating: RBC Capital · Outperform → Outperform
  • Nov 14, 2025Downgrade: Needham · Buy → Hold
  • Nov 14, 2025Downgrade: HC Wainwright & Co. · Buy → Neutral
  • Nov 18, 2025Downgrade: Guggenheim · Buy → Neutral
Signals (7)
NameDateAgo
MACD: Sell SignalDec 4, 202511 months ago
MACD: Buy SignalNov 14, 202511 months ago
RSI: OverboughtNov 14, 202511 months ago
SMA: BullishNov 7, 202512 months ago
SMA: BearishNov 4, 202512 months ago
MACD: Sell SignalOct 16, 20251 year ago
RSI: OverboughtOct 9, 20251 year ago

Financial health

Altman Z-Score

32.61 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2015: -7.3×FY 2016: -3.1×FY 2017: -2.1×FY 2018: -1.0×FY 2019: -2.9×FY 2020: -1.1×FY 2021: -1.6×FY 2022: -1.6×FY 2023: -3.0×FY 2024: -1.0×
FY 2015 5y median -1.6× FY 2024
P/S 134×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 5.5×FY 2020: 6.9×FY 2021: 1.3×FY 2022: 0.8×FY 2023: 3.0×FY 2024: 134×
FY 2015 5y median 3.0× FY 2024
P/B 1.0×
FY 2015: 2.3×FY 2016: 1.7×FY 2017: 2.0×FY 2018: 1.0×FY 2019: 3.0×FY 2020: 7.8×FY 2021: 3.1×FY 2022: -3.7×FY 2023: -8.5×FY 2024: 1.0×
FY 2015 5y median 1.0× FY 2024
P/FCF -1.0×
FY 2015: -8.7×FY 2016: -3.8×FY 2017: -2.4×FY 2018: -1.1×FY 2019: -4.0×FY 2020: -1.5×FY 2021: -2.6×FY 2022: -1.8×FY 2023: -3.0×FY 2024: -1.0×
FY 2015 5y median -1.8× FY 2024
EV/EBITDA 0.1×
FY 2015: -4.0×FY 2016: -1.2×FY 2017: -1.0×FY 2018: 0.1×FY 2019: -1.8×FY 2020: -0.8×FY 2021: -0.2×FY 2022: -0.6×FY 2023: -1.5×FY 2024: 0.1×
FY 2015 5y median -0.6× FY 2024
EV/Sales -12.2×
FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 3.7×FY 2020: 4.6×FY 2021: 0.2×FY 2022: 0.3×FY 2023: 1.7×FY 2024: -12.2×
FY 2015 5y median 0.3× FY 2024
FCF Yield -103.5%
FY 2015: -11.5%FY 2016: -26.7%FY 2017: -42.2%FY 2018: -93.6%FY 2019: -24.9%FY 2020: -65.7%FY 2021: -38.0%FY 2022: -54.1%FY 2023: -33.0%FY 2024: -103.5%
FY 2015 5y median -54.1% FY 2024

Profitability

Gross Margin 100.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -121.9%FY 2020: 100.0%FY 2021: -47.4%FY 2022: 100.0%FY 2023: -57.9%FY 2024: 100.0%
FY 2015 5y median 100.0% FY 2024
Operating Margin -13811.9%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -199.5%FY 2020: -595.4%FY 2021: -85.2%FY 2022: -52.0%FY 2023: -116.2%FY 2024: -13811.9%
FY 2015 5y median -116.2% FY 2024
Net Margin -13319.8%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: -196.5%FY 2020: -597.6%FY 2021: -85.7%FY 2022: -52.1%FY 2023: -98.5%FY 2024: -13319.8%
FY 2015 5y median -98.5% FY 2024
ROE -104.0%
FY 2015: -31.0%FY 2016: -54.6%FY 2017: -93.3%FY 2018: -99.8%FY 2019: -108.6%FY 2020: -673.0%FY 2021: -196.9%FY 2022: 232.6%FY 2023: 279.3%FY 2024: -104.0%
FY 2015 5y median -104.0% FY 2024
ROIC -105.5%
FY 2015: -31.1%FY 2016: -49.4%FY 2017: -80.0%FY 2018: -91.5%FY 2019: -84.2%FY 2020: -240.9%FY 2021: -93.8%FY 2022: -459.1%FY 2023: -2967.1%FY 2024: -105.5%
FY 2015 5y median -240.9% FY 2024
ROA -79.1%
FY 2015: -29.3%FY 2016: -45.0%FY 2017: -70.5%FY 2018: -74.6%FY 2019: -59.6%FY 2020: -119.3%FY 2021: -56.4%FY 2022: -70.7%FY 2023: -34.2%FY 2024: -79.1%
FY 2015 5y median -70.7% FY 2024

Growth (YoY)

Revenue -94.5%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: -42.3%FY 2021: 310.8%FY 2022: 30.0%FY 2023: -63.9%FY 2024: -94.5%
FY 2015 FY 2024
Operating Income -550.8%
FY 2015: -178.0%FY 2016: -49.9%FY 2017: -15.0%FY 2018: -13.6%FY 2019: 34.1%FY 2020: -72.2%FY 2021: 41.2%FY 2022: 20.7%FY 2023: 19.2%FY 2024: -550.8%
FY 2015 FY 2024
EPS (diluted) -409.5%
FY 2015: 83.9%FY 2016: -42.2%FY 2017: 4.2%FY 2018: 28.4%FY 2019: 41.3%FY 2020: -34.5%FY 2021: 55.1%FY 2022: 40.6%FY 2023: 45.4%FY 2024: -409.5%
FY 2015 FY 2024
Free Cash Flow -670.2%
FY 2015: -211.8%FY 2016: -48.1%FY 2017: -25.0%FY 2018: -13.3%FY 2019: 49.8%FY 2020: -91.1%FY 2021: 53.7%FY 2022: -13.1%FY 2023: 19.8%FY 2024: -670.2%
FY 2015 FY 2024

Financial Health

Current Ratio 4.3×
FY 2015: 18.1×FY 2016: 11.8×FY 2017: 6.4×FY 2018: 3.9×FY 2019: 2.2×FY 2020: 1.5×FY 2021: 2.1×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 4.3×
FY 2015 5y median 1.5× FY 2024
Quick Ratio 4.3×
FY 2015: 18.1×FY 2016: 11.8×FY 2017: 6.5×FY 2018: 3.9×FY 2019: 2.2×FY 2020: 1.5×FY 2021: 2.2×FY 2022: 1.1×FY 2023: 0.8×FY 2024: 4.3×
FY 2015 5y median 1.5× FY 2024
Debt / Equity 0.0×
FY 2015: 0.0×FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.2×FY 2019: 0.3×FY 2020: 0.7×FY 2021: 0.2×FY 2022: -0.1×FY 2023: -0.6×FY 2024: 0.0×
FY 2015 5y median 0.0× FY 2024
Net Debt / EBITDA 1.1×
FY 2015: 3.4×FY 2016: 2.0×FY 2017: 1.2×FY 2018: 1.0×FY 2019: 0.9×FY 2020: 0.4×FY 2021: 1.4×FY 2022: 1.0×FY 2023: 1.2×FY 2024: 1.1×
FY 2015 5y median 1.1× FY 2024
Interest Coverage 0.0×
FY 2015: -269×FY 2016: -179×FY 2017: -7960×FY 2018: -101×FY 2019: 0.0×FY 2020: -274×FY 2021: -199×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2015 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2015 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31